Literature DB >> 17343478

Determination of fluence rate and temperature distributions in the rat brain; implications for photodynamic therapy.

Even Angell-Petersen1, Henry Hirschberg, Steen J Madsen.   

Abstract

Light and heat distributions are measured in a rat glioma model used in photodynamic therapy. A fiber delivering 632-nm light is fixed in the brain of anesthetized BDIX rats. Fluence rates are measured using calibrated isotropic probes that are positioned stereotactically. Mathematical models are then used to derive tissue optical properties, enabling calculation of fluence rate distributions for general tumor and light application geometries. The fluence rates in tumor-free brains agree well with the models based on diffusion theory and Monte Carlo simulation. In both cases, the best fit is found for absorption and reduced scattering coefficients of 0.57 and 28 cm(-1), respectively. In brains with implanted BT(4)C tumors, a discrepancy between diffusion and Monte Carlo-derived two-layer models is noted. Both models suggest that tumor tissue has higher absorption and less scattering than normal brain. Temperatures are measured by inserting thermocouples directly into tumor-free brains. A model based on diffusion theory and the bioheat equation is found to be in good agreement with the experimental data and predict a thermal penetration depth of 0.60 cm in normal rat brain. The predicted parameters can be used to estimate the fluences, fluence rates, and temperatures achieved during photodynamic therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17343478     DOI: 10.1117/1.2709882

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  8 in total

1.  Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain.

Authors:  Marlon S Mathews; David Chighvinadze; H Michael Gach; Francisco A Uzal; Steen J Madsen; Henry Hirschberg
Journal:  Lasers Surg Med       Date:  2011-11       Impact factor: 4.025

2.  FEF inactivation with improved optogenetic methods.

Authors:  Leah Acker; Erica N Pino; Edward S Boyden; Robert Desimone
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-02       Impact factor: 11.205

3.  The effects of low irradiance long duration photochemical internalization on glioma spheroids.

Authors:  Diane Shin; Lina Nguyen; Mai T Le; David Ju; Jimmy N Le; Kristian Berg; Henry Hirschberg
Journal:  Photodiagnosis Photodyn Ther       Date:  2019-05-07       Impact factor: 3.631

4.  The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids.

Authors:  Marlon S Mathews; Even Angell-Petersen; Rogelio Sanchez; Chung-Ho Sun; Van Vo; Henry Hirschberg; Steen J Madsen
Journal:  Lasers Surg Med       Date:  2009-10       Impact factor: 4.025

5.  Increased nanoparticle-loaded exogenous macrophage migration into the brain following PDT-induced blood-brain barrier disruption.

Authors:  Steen J Madsen; H Michael Gach; Seok Jin Hong; Francisco A Uzal; Qian Peng; Henry Hirschberg
Journal:  Lasers Surg Med       Date:  2013-08-30       Impact factor: 4.025

6.  Motexafin gadolinium enhances the efficacy of aminolevulinic acid mediated-photodynamic therapy in human glioma spheroids.

Authors:  Steen J Madsen; Marlon S Mathews; Even Angell-Petersen; Chung-Ho Sun; Van Vo; Rogelio Sanchez; Henry Hirschberg
Journal:  J Neurooncol       Date:  2008-09-06       Impact factor: 4.130

7.  Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.

Authors:  L Teng; M Nakada; S-G Zhao; Y Endo; N Furuyama; E Nambu; I V Pyko; Y Hayashi; J-I Hamada
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640

8.  Optical Properties and Fluence Distribution in Rabbit Head Tissues at Selected Laser Wavelengths.

Authors:  Alaa Sabeeh Shanshool; Ekaterina Nikolaevna Lazareva; Omnia Hamdy; Valery Victorovich Tuchin
Journal:  Materials (Basel)       Date:  2022-08-18       Impact factor: 3.748

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.